Patents by Inventor Laura Plosila

Laura Plosila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 7914795
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: March 29, 2011
    Assignee: Emergent Product Development Gaithersburg, Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman
  • MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
    Publication number: 20100021492
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP 106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP 106 polypeptides and OMP 106-derived polypeptides in animals.
    Type: Application
    Filed: August 14, 2009
    Publication date: January 28, 2010
    Inventors: Kenneth TUCKER, Laura PLOSILA, Ulrich F. TILLMAN
  • outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 7576179
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: August 18, 2009
    Assignee: Emergent Product Development of Gaithersburg, Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman
  • MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
    Publication number: 20080145916
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Application
    Filed: October 26, 2007
    Publication date: June 19, 2008
    Inventors: Kenneth Tucker, Laura Plosila
  • outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
    Patent number: 7341727
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: March 11, 2008
    Assignee: Emergent Product Development Gaithersburg Inc.
    Inventors: Kenneth Tucker, Laura Plosila
  • Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Publication number: 20070087019
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Application
    Filed: October 16, 2006
    Publication date: April 19, 2007
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich Tillman
  • outer membrane protein-106 polypeptide, gene sequences and uses thereof
    Patent number: 7128910
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: October 31, 2006
    Assignee: Emergent Product Development Gaithersburg Inc.
    Inventors: Kenneth Tucker, Laura Plosila
  • Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Publication number: 20020177200
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Application
    Filed: March 20, 2001
    Publication date: November 28, 2002
    Applicant: Antex Biologics Inc.
    Inventors: Kenneth Tucker, Laura Plosila
  • Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
    Patent number: 6214981
    Abstract: The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: April 10, 2001
    Assignee: Antex Biologics Inc.
    Inventors: Kenneth Tucker, Laura Plosila, Ulrich F. Tillman